Welcome to Rhea Pharmaceutical Sciences

Rhea is a Singapore-based biopharmaceutical company under the umbrella of the Charoen Pokphand Indonesia Group/ Central Proteina Prima Group. Rhea is specialized in small molecule design, synthesis, as well as research in broader infectious disease areas with great unmet medical need. Currently, our research has been focusing on the development of various small molecules as therapeutics for viral, bacterial and fungal infections for both, human and veterinary applications. An additional area of interest with some of our recently discovered molecules are viruses from the Coronavirus family including SARS-CoV-2, as well as other viral families such as the Herpes Virus group, the African Swine Fever Virus and drug resistant fungi such as Candida Albicans, Saccaromyces cerevisiae and Aspergillus brasiliensis. We have recently identified compounds with potent activity against multi-drug resistant bacteria like Staphylococcus aureus, E. Coli, Salmonella, Clostridium difficile, and Neisseria gonorrhoeae.